Functional analysis of adrenocorticotropic-hormone–producing pituitary cells derived from human pluripotent stem cells in murine and primate models of hypopituitarism

2026.10.02

Research and Development

Announcement by Sumitomo Pharma America, Inc. (SMPA) of the First Patient Receiving a Transplant in the Phase 1/2 Study of an iPSC-Derived Retinal Sheet Therapy for Retinitis Pigmentosa in the U.S.

2026.08.13

Research and Development

Development of the Regenerative Medicine Product “AMCHEPRY®” Receives the 10th Japan Bioindustry Award

2026.07.15

Research and Development

Announcement by Sumitomo Pharma America, Inc. (SMPA) Regarding the U.S. Orphan Drug Designation for an Allogeneic iPS cell-derived Retinal Sheet (3-dimensional retina) as a Treatment for Retinitis Pigmentosa

2026.03.24

Research and Development